Home/Filings/4/0001854270-25-000034
4//SEC Filing

Rajangam Kanya 4

Accession 0001854270-25-000034

CIK 0001854270other

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 4:23 PM ET

Size

8.5 KB

Accession

0001854270-25-000034

Insider Transaction Report

Form 4
Period: 2025-03-10
Rajangam Kanya
Pres. & Chief Med. & Dev. Off.
Transactions
  • Conversion

    Common Stock

    2025-03-10$2.25/sh+33,000$74,25033,000 total(indirect: By Trust)
  • Conversion

    Series A Convertible Preferred Stock

    2025-03-10$2250.00/sh33$74,2500 total(indirect: By Trust)
    Exercise: $2.25From: 2025-03-10Common Stock (33,000 underlying)
Holdings
  • Common Stock

    86,984
Footnotes (2)
  • [F1]The reporting person and her spouse are trustees of the Iyer Family Revocable Trust dated Aug 26 2012. Each of the reporting person and her spouse have voting and dispositive power over the Series A Preferred Stock, Common Stock and Warrants. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F2]The shares of Series A Convertible Preferred Stock have no expiration date.

Issuer

Senti Biosciences, Inc.

CIK 0001854270

Entity typeother

Related Parties

1
  • filerCIK 0001816676

Filing Metadata

Form type
4
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 4:23 PM ET
Size
8.5 KB